July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
The effect of cornea preservation time on Descemet membrane endothelial keratoplasty outcomes.
Author Affiliations & Notes
  • Maria Elena Montpetit Gonzalez
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Johanna Choremis
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Michèle Mabon
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Tanguy Boutin
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Leila Mejdoub
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Isabelle Brunette
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Julia C Talajic
    Ophthalmology - Cornea, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Université de Montréal, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships   Maria Elena Montpetit Gonzalez, Fundación Alfonso Martín Escudero (F); Johanna Choremis, Allergan (C), Allergan (R), Bausch and Lomb (C), Labtivian-Thea (C), PRN pharmaceuticals (P), Santen (C), Santen (R), Shire (C), Shire (R); Michèle Mabon, PRN pharmaceuticals (P); Tanguy Boutin, None; Leila Mejdoub, None; Isabelle Brunette, Abbott Medical Optics (F), Canadian Institutes of Health Research (CIHR) (F), European Society of Cataracts and Refractive Surgeons (ESCRS) (F), Fonds de recherche du Québec - Santé (FRQS) (F), Fonds de recherche en Ophtalmologiede l'Université de Montréal (FROUM) (F), The Natural Sciences and Engineering Research Council of Canada (NSERC) (F), US PRovisional 62/557,503: 05015490-117USPR (P), Valeant Canada (F); Julia Talajic, Fonds de recherche en ophtalmologie de l'Université de Montréal (FROUM) (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Elena Montpetit Gonzalez, Johanna Choremis, Michèle Mabon, Tanguy Boutin, Leila Mejdoub, Isabelle Brunette, Julia C Talajic; The effect of cornea preservation time on Descemet membrane endothelial keratoplasty outcomes.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3820.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The average preservation time (PT) of donor corneas at Hôpital Maisonneuve-Rosemont (HMR) is 8 to 9 days according to Héma-Québec, but corneas are frequently used up to 14 days. In the United States the vast majority of corneas are stored fewer than 8 days as many surgeons refuse donor tissue stored for longer. Our overall goal is to determine if a longer PT has an impact on the outcome of Descemet membrane endothelial keratoplasty (DMEK) cornea transplants.

Methods : This ambispective observational study involves 265 eyes of 219 patients who consecutively underwent DMEK at HMR between April 2015 and July 2018. Eyes were divided in groups: Group 1: Donor cornea preserved ≤7 days, and Group 2: >7 to 14 days. The primary outcome was central endothelial cell density (ECD) at 12 months post-DMEK, and secondary outcome parameters were graft failure and rebubbling rate.

Results : The 12 months follow-up will be completed for all patients in July 2019. Preliminary results on 36 eyes of 32 patients (Group 1: n=17 and Group 2: n=19). The mean age at surgery was 68 years (range: 48-88 years; 50.2% men). Mean follow-up time was 18.3 months. Mean (±SD) preoperative donor ECD was 2697±337 cells/mm2 in Group 1 and 2840±319 cells/mm2 in Group 2. At 1 year, mean ECD decreased to 1261±559 cells/mm2 and 1190±451 cells/mm2, respectively (mean difference, 71 cells/mm2; 95% CI [-271.65 to 413.65]; p= 0.68). This represented an endothelial cell loss of 53±18% in Group 1 and 58±17% in Group 2 (mean difference 5; 95% CI [-6.86 to 16.86]; p= 0.49). 65% of central ECD in Group 1 were over 1000 cells/mm2 compared to 53% in Group 2. Rebubbling and failure rates were 29% and 0% in Group 1 and 26% and 11% in Group 2. Mean delay from death to preservation was 11.56±5.55 hours in Group 1 and 12.49±6.18 hours in Group 2 (mean difference 0.93; 95% CI [-3.07 to 4.93]; p= 0.64). Mean delay from stripping to surgery was 2±1.13 days (range: 0-4 days) for Group 1, and 2±1.57 days (range: 0-6 days) for Group 2 (mean difference 0.24; 95% CI [-0.54 to 1.02]; p= 0.59).

Conclusions : Preliminary results indicate that PT did not significantly affect DMEK outcomes. Follow-up on a larger sample size will be presented. If long PTs negatively impact DMEK this will affect eye bank storage worldwide. Conversely, safe use of longer PTs will allow for an increased DMEK donor pool, reducing waiting lists and facilitating tissue access.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×